Eli Lilly’s GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025.
New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval
Related Posts
-
PHOTOS: A look back at Bill Fennelly’s 32 years at Iowa State
Bill Fennelly’s legendary 32-year run at Iowa State is coming to an end after the…
-
PHOTOS: A look back at Bill Fennelly’s 32 years at Iowa State
Bill Fennelly’s legendary 32-year run at Iowa State is coming to an end after the…
-
Longtime Iowa State women’s basketball coach Bill Fennelly announces retirement after 2026-27 season
The winningest coach in Iowa State history will leave after his 32nd season.
-
Your houseplants’ summer vacation is over—here’s how to bring them inside
When nighttime temperatures dip into the 40s, it’s time to bring your tropical plants indoors.
Leave a Reply